Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Relay Therapeutics (RLAY) Intangibles (2021 - 2025)

Historic Intangibles for Relay Therapeutics (RLAY) over the last 5 years, with Q1 2025 value amounting to $2.3 million.

  • Relay Therapeutics' Intangibles changed 0.0% to $2.3 million in Q1 2025 from the same period last year, while for Mar 2025 it was $2.3 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $2.3 million for FY2024, which is 0.0% changed from last year.
  • Relay Therapeutics' Intangibles amounted to $2.3 million in Q1 2025, which was down 0.0% from $2.3 million recorded in Q4 2024.
  • Relay Therapeutics' Intangibles' 5-year high stood at $2.3 million during Q2 2021, with a 5-year trough of $2.3 million in Q2 2021.
  • Over the past 5 years, Relay Therapeutics' median Intangibles value was $2.3 million (recorded in 2021), while the average stood at $2.3 million.
  • Examining YoY changes over the last 5 years, Relay Therapeutics' Intangibles showed a top increase of 0.0% in 2022 and a maximum decrease of 0.0% in 2022.
  • Relay Therapeutics' Intangibles (Quarter) stood at $2.3 million in 2021, then changed by 0.0% to $2.3 million in 2022, then changed by 0.0% to $2.3 million in 2023, then changed by 0.0% to $2.3 million in 2024, then changed by 0.0% to $2.3 million in 2025.
  • Its last three reported values are $2.3 million in Q1 2025, $2.3 million for Q4 2024, and $2.3 million during Q3 2024.